Skip to content

Motorised Probe Holder Assisting Prostate Biopsies

Pilot Study of a Motorised Probe Holder Assisting Prostate Biopsies

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02132975
Acronym
PROSBOT-Apollo
Enrollment
20
Registered
2014-05-07
Start date
2014-05-31
Completion date
2016-05-31
Last updated
2016-10-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Keywords

prostate, cancer

Brief summary

Study, for the first time in clinical conditions, the potential contribution, in terms of accuracy, of the motorised probe holder during prostate biopsies.

Interventions

DEVICEBiopsies using Apollo and UroStation®

Apollo : Motorised probe handler for prostate biopsies

PROCEDUREBiopsies using UroStation® (image fusion)

Sponsors

Pitié-Salpêtrière Hospital
CollaboratorOTHER
Institute for Intelligent Systems and Robotics
CollaboratorUNKNOWN
Clinical Investigation Centre for Innovative Technology Network
CollaboratorNETWORK
AdministrateurCIC
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* of-age patient * patient for whom a prostate biopsies session is planned * patient affiliated to the social security or equivalent * patient having a target identified on MRI * Written informed consent

Exclusion criteria

* contraindication * patient wearing a mechatronic device * patient concerned by the L1121-6 à 8 of the health public code

Design outcomes

Primary

MeasureTime frame
Distance between virtual and effective biopsy, in the two arms8 months

Secondary

MeasureTime frameDescription
Success rate in locking/releasing the probe combined with success rate in performing a full exploration of the prostate8 months
Probe holder positions error between virtual and effective biopsy8 months
User satisfaction2 hours* biopsies session duration * device manageability * device unwiediness * contribution of the lock of the probe * set up, cleaning * global satisfaction
Safety Evaluation2 hours* number of time the device couldn't be started * number of times the emergency button was pushed * number of time the biopsy couldn't entirely be done using the device * number of time the device protections had to be repositioned

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026